Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhancing Protection Against Influenza and COVID-19 for Pregnant Women and Medically at Risk Children (EPIC Study)

NCT05613751 is registered in ClinicalTrials.gov with University of Adelaide as lead sponsor.

NCT NCT05613751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05613751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhancing Protection Against Influenza and COVID-19 for Pregnant Women and Medically at Risk Children (EPIC Study)
Lead sponsor
University of Adelaide
Phase
Not applicable
Overall status
Unknown status
Start date
October 26, 2022
Completion date
December 31, 2024
Enrollment
1,038 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, influenza